Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

HemoGenyx Shares Slide Even as CAR-T Commercialisation Plan Advances Into Estonia

A definitiveManufacturingdeal with Estonia's Cellin Technologies marks a concrete step toward earlyRevenuefor HemoGenyx's CAR-T leukaemia therapy, yet the HEMO share price fell in the days after the announcement as investors weighed execution and funding risk.

Divya Sood | 13 August 2026

ProBiotix Health Share Price Rallies as Record Trading, Profitability and Global Expansion Fuel Investor Optimism

ProBiotix Health develops and commercialises scientifically validated probiotic products focused primarily on cardiometabolic health. Its portfolio is built around proprietary bacterial strains used in supplements addressing cholesterol management, vascular wellness and healthy ageing. The stock’s recent rise appears connected to strong interim performance, improving …

Ankur Sharma | 13 August 2026

Could Provexis Unlock Major Value From Fruitflow Heart-Health Technology and Its Expanding Global Customer Base?

Provexis has attracted renewed investor attention afterLSE:PXS gained 7.26% on 13 August 2026.

Ankur Sharma | 13 August 2026

Could Oxford BioDynamics Shares Rise 15.38% as a £9.15m Funding Boost Changes the Outlook?

Oxford BioDynamics has attracted renewed investor attention on 13 August 2026 afterLSE:OBD shares climbed 15.38%.

Ankur Sharma | 13 August 2026

Aptamer Group Shares Gain 5.24%: What Investors Need to Know About Optimer, Radiopharmaceuticals and Diagnostics

Aptamer Group PLC has attracted renewed attention on13 August 2026, withLSE:APTA rising 5.24%.

Ankur Sharma | 13 August 2026

Arecor Therapeutics Shares Jump 6.89%: Is AT278 Becoming the Key Catalyst for LSE:AREC?

Arecor Therapeutics PLC has moved sharply higher on 13 August 2026, withLSE:AREC gaining 6.89%and attracting renewed attention among investors looking for momentum across UK-listed healthcare and biotechnology stocks.

Ankur Sharma | 13 August 2026

Why CRISM Therapeutics LSE:CRTX shares are rising today as ChemoSeed enters a critical clinical stage

CRISM Therapeutics Corporation LSE:CRTX is attracting renewed investor attention after its shares climbed5.00% on 13 August 2026.

Ankur Sharma | 13 August 2026

LSE:IMM Shares Jump 6.89%: Is Kapiglucagon Becoming the Next Major ImmuPharma Catalyst?

ImmuPharma PLC has returned to the spotlight on 13 August 2026 afterLSE:IMM gained 6.89%, extending investor attention around the company's developing pharmaceutical pipeline.

Ankur Sharma | 13 August 2026

Adocia Puts Phase 3 Data Centre Stage — Could This French Biotech Be One Catalyst Away From a Major Re-Rating?

Adocia (Euronext Paris: ADOC) is a clinical-stage biotechnology company that designs innovative formulations of therapeutic proteins and peptides, chiefly for diabetes and, increasingly, obesity. Its core intellectual property is the BioChaperone platform — proprietary molecules that can be combined with existing drugs to change …

Ankur Sharma | 13 August 2026

Advanced Medical Solutions: Can Tissue-Healing Growth and the Peters Deal Power the Next Leg Higher?

Advanced Medical Solutions (LSE:AMS) is a UK-headquartered medical-technology group specialising in tissue-healing products — the adhesives, sutures, sealants, haemostats and dressings used to close and manage wounds. It runs two divisions. The larger, Surgical, sells tissue adhesives under the LiquiBand and Liquifix brands, surgical …

Ankur Sharma | 13 August 2026
Support

Hi! How can we help you today?

Loading…